Borgeson Blake

Recursion Pharmaceuticals, Inc. · Director

Borgeson Blake is listed in filings as Director at Recursion Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jul 9, 2026, including sale activity. Recent filings connect the profile to Recursion Pharmaceuticals, Inc. (RXRX). The current snapshot covers public activity from Jun 4, 2026 to Jul 9, 2026. Reported amounts are shown as $158.5K to $110.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Latest Trades

CompanyValueActionPriceLast Price
Recursion Pharmaceuticals, Inc.RXRX$159k40k sharesSellJul 7, 2026$3.96$3.31